Menu

Physicians and patients expect their platelets to be safe and effective.

100% of leading hospitals1 implemented INTERCEPT® Platelets.

protects patients

improves availability

delivers economic value and operational efficiencies

Explre how INTERCEPT® Platelets go beyond.

INTERCEPT® Platelets

inactivate bacteria AND
viruses, protozoans, and leukocytes2

INTERCEPT® Platelets

have a proven and established safety record3-7

INTERCEPT® Platelets

day 1 release means potential for earlier receipt, resulting in younger, fresher platelets8

INTERCEPT® Platelets

proactive approach to pandemic preparedness through inactivation of certain emerging
pathogens9-11

INTERCEPT® Platelets

one transfusion-ready inventory for all patients that commands substantial hospital outpatient reimbursement2,8,12

INTERCEPT® Platelets

avoid additional costs due to reduced risk of TTIs, sepsis and TA-GVHD13-14

protects patients

improves availability

delivers economic value and operational efficiencies

Having seen first-hand the grief caused—not just to the patient’s family, but to hospital staff—when a patient dies after receiving bacterially contaminated platelets, I made it a priority to avoid that by bringing pathogen reduced platelets into our inventory, increasing safety for all patient populations . . . Receiving pathogen reduced platelets a day earlier than conventional platelets improves our platelet inventory management, and we use our irradiator less which streamlines our workflow. INTERCEPT® Platelets are our first choice.

PREVENTS Replication and INACTIVATES Pathogens

Explre how INTERCEPT® Platelets go beyond for your patients.

LEARN MORE
  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • *This is the opinion of Mary Berg, MD and not necessarily the opinion of UC Health, University Hospital or the University of Colorado School of Medicine.